Int. J. Pharm. Sci. Rev. Res.

, 23(2), Nov – Dec 2013; nᵒ 41, 237-246 ISSN 0976 – 044X

Review Article

Review on: Synthesis, Chemistry and Therapeutic Approaches of Imidazole Derivatives

1* 2
Rajat Ghosh , Biplab De
1. Department of Pharmacy, Tripura University (A Central University) Suryamaninagar, Tripura-799022, India.
2. Regional Institute of Pharmaceutical Science & Technology, Abhoynagar, Tripura-799005, India.
*Corresponding author’s E-mail: [email protected]

Accepted on: 03-10-2013; Finalized on: 30-11-2013.

ABSTRACT
Imidazole is a planar, five membered heteroaromatic molecule with pyrrole type and pyridine type annular nitrogens. Several
approaches are available for synthesis of imidazoles from alpha halo ketones, aminonitrile, aldehyde etc. Reactivity of imidazole and
benzimidazole is referred from sets of resonance structure in which the dipolar contributors have finite importance. Electrophilic
nd th th
substitution takes place at the 2 , 4 and 5 position in the imidazole ring, it is much less likely to become involved in nucleophilic
substitution reaction unless there is a strongly electron withdrawing substituents elsewhere in the ring. This interesting group of
heterocyclic compound has diverse biological activities such as antimicrobial, anticancer, analgesic, anti-inflammatory, antiviral,
anthelmintic, anticonvulsant, antiulcer, anti-allergic activity etc. In the present article we review the various synthetic approaches,
chemistry and biological activities reported by researchers throughout the world on imidazole.
Keywords: Imidazole, Electrophilic Substitution, Antimicrobial, Analgesic- anti-inflammatory, Antiviral.

INTRODUCTION All these imidazole synthesizing methods were limited in

scope. So the most general method was the reaction of

I midazole is a planar five-membered ring system with

three (3) carbon and two (2) nitrogen atom in 1 and 3
positions. Imidazole was first named as glyoxaline. It is
amphoteric in nature, susceptible to electrophilic and
nucleophilic attack. It also occurs in the purine nucleus &
potassium thiocyanate on α-amino aldehydes of ketones
(as hydrochlorides) & an imidazoline thione, was
desulphurized with Raney nickel or by oxidation with
nitric acid.1 Another route had been developed by
researchers with α-bromoketone & an amidine.
amino acid histidine; 4-amino-imidazole-5-carboxamide
Afterwards, another general method was developed to
occurs naturally as a riboside (or, ribotide).1
synthesize imidazole by the cyclization of α-
3 4 acylaminoketones (behave as 1, 4-diketo compounds).1 D.
N
S. Ermolat’ev et al. reported one-pot microwave-assisted
5 protocol for the synthesis of substituted 2-amino-1H-
2
imidazoles.2 Michael A. Schmidt and Martin D. Eastgate
N reported regioselective synthesis of 1,4-disubstituted
H
1 imidazoles.3 Zahra Rezaei et al. reported design, synthesis
SYNTHESIS OF IMIDAZOLES and antifungal activity of some new imidazole and triazole
derivatives.4 V. A. Chornous et al. mentioned 2-Aryl-4-
Imidazole may be prepared by the reaction of ammonia chloro-1-methyl(aryl)-1H-imidazole-5-carbaldehydes
on glyoxal. The mechanism of this reaction was uncertain, synthesis.5 V. A. Chornous along with A. N. Grozav and M.
but one suggestion had been given that one molecule of V. Vovk, reported synthesis of polyfunctional
glyoxal breaks down into formic acid & formaldehyde, imidazoles;1-aryl-2,4-dihalo-1H-imidazole-5-carboxylic
1
and then the latter reacts as follows : acids and their derivatives.6 Biswanath das et al. reported
(i) CHO + H2O HCHO synthesis of 5-substituted 2,3-diphenyl and 5-substituted
1-aryl-2,3-diphenyl imidazoles using polyethylene glycol.7
CHO
N
(ii) CHO + 2NH3 + HCHO + 3H2O Cheng-he zhou et al. prepared a series of ether bis-
8
CHO imidazoles and their derivatives. Majid M. Heravi et al.
N
H reported acidic ionic liquid {[(CH2)4SO3HMIM][HSO4]} a
Radziszewsky explained a general method for preparing green media for the simple and straight forward synthesis
imidazoles by reaction of an α-dicarbonyl compound, of 2,4,5-trisubstituted imidazoles.9 Even Majid M. Heravi
1 et al. mentioned efficient and reusable catalyst for the
ammonia & an aldehyde. This method was improved by
Bredereck et al., who heated α-diketones with formamide synthesis of 2,4,5-trisubstituted imidazoles under solvent-
& formaldehyde (or other aldehydes) at 180-200 C.
o free conditions.10 Sidhanath V. Bhosale et al. reported
Imidazole itself was best prepared by the action of one-pot synthesis of 2,4,5-trisubstituted imidazoles using
ammonia on a mixture of formaldehyde & tartaric acid MoO3/SiO2, an efficient and recyclable catalyst.11 Ahmad
dinitrate (dinitrotartaric acid), and then heating the Shaabani et al. mentioned 1,1,3,3‐N,N,N′,N′
dicarboxylic acid in quinolone in the presence of copper. ‐tetramethylguanidiniumtrifluoroacetate ionic liquid–

International Journal of Pharmaceutical Sciences Review and Research

Available online at www.globalresearchonline.net 237
Int. J. Pharm. Sci. Rev. Res., 23(2), Nov – Dec 2013; nᵒ 41, 237-246 ISSN 0976 – 044X

promoted efficient one‐pot synthesis of trisubstituted

imidazoles.12 Mohammad R. Mohammadizadeh et al.
reported trifluoroacetic acid as an efficient catalyst for
one-pot synthesis of 1,2,4,5-tetrasubstituted imidazoles
13
under microwave-assisted solvent-free condition. Amphotericity
14,15
CHEMISTRY OF IMIDAZOLE Imidazole is amphoteric. That is, it can function as both an
Imidazole is having properties similar to both pyrrole and acid and as a base. As an acid, the pKa of imidazole is 14.5,
pyridine. The electrophilic reagent would attack the making it less acidic than carboxylic acids, phenols, and
unshared electron pair on N-3, but not on the ‘pyrrole’ imides, but slightly more acidic than alcohols. The acidic
nitrogen since it is the part of the aromatic sextet. proton is located on N-1. As a base, the pKa of the
Imidazole ring is susceptible to electrophilic attack on an conjugate acid is approximately 7, making imidazole
annular carbon, it is much less likely to become involved approximately sixty times more basic than pyridine. The
in nucleophilic substitution reaction unless there is a basic site is N-3. Protonation gives the imidazolium
strongly electron withdrawing substituents elsewhere in cation, which is symmetrical.
the ring. In the absence of such activation the position Electrophillic substitution
most prone to nucleophilic attack is C-2. The fused
benzene ring in benzimidazoles provides sufficient Imidazole possess increased reactivity towards
electron withdrawal to allow a variety of nucleophilic electrophillic attack. It is more susceptible to
substitution reaction at C-2. Imidazole exists in two electrophillic attack than pyrazole or thiazole and more so
equivalent tautomeric forms, because the proton can be than from furan and thiophene also. It is evident that the
located on either of the two nitrogen atoms. Imidazole is attack takes place at the 4th and 5th position in imidazole
a highly polar compound, as evidenced by a calculated ring. It may be noticed that the attack at C-2 involves a
dipole of 3.61D. It is highly soluble in water. The canonical form which is highly unfavored at positive N at
compound is classified as aromatic due to the presence of position 3.
a sextet of π-electrons, consisting of a pair of electrons BIOLOGICAL ACTIVITY OF IMIDAZOLE
from the protonated nitrogen atom and one from each of
the remaining four atoms of the ring. Imidazole and its derivatives could be considered as
Some resonance structures of imidazole are shown possible antimicrobial, anticancer, analgesic,
below: antiinflammatory, antiviral, anthelmintic, anticonvulsant,
antiulcer, antiallergic activity etc. This paper includes
different biological activities of imidazole and its
derivatives.

Table 1: Imidazole as Antimicrobial agent

Name of author Structure / Compound Active against strains
Mohd Amir et al.16 S. aureus, E. coli, B. subtilis, C.
albicans.

Dennis Dixon et al.17 C. albicans , C. tropicalis,

Comparison of the
in Vitro Antifungal C. parapsilosis.
Activities of
Miconazole and a
New Imidazole.

18
R. F. Cosgrove et al. Amphotericin B in S. cerevisiae
Combination with the
Imidazole Antifungal
Compounds
Clotrimazole and
Miconazole
R. Wyler et al.19 An Imidazole Derivative A fumigatus ,C albicans M
(Econazole) as an Antifungal pusillus,
Agent in Cell Culture Penicillium sp.
Systems

International Journal of Pharmaceutical Sciences Review and Research

Available online at www.globalresearchonline.net 238
Int. J. Pharm. Sci. Rev. Res., 23(2), Nov – Dec 2013; nᵒ 41, 237-246 ISSN 0976 – 044X

Roberto Di Santo et al.20 C. albicans

21
Andrea Tafi et al. C. albicans, C. glabrata, C.
krusei

Armando Rossello et al. 22 C. albicans

Keith A. M. Walker et al.23 C. albicans

Andrea Tafi et al.24 C. albicans.

Balekudru Devadas et al.25 C. albicans,

C. neoformans.

Keith A. M. Walker et al.26 M. audouini ,M. gypseum

C. albicans ,C. neoformans
S. aureus ,C. acne etc.

J. Heeres et al.27 M. canis,C. neoformans

C. tropicalis,C. albicans
P. verrucosa, E. insidiosa

Raymond G. Lovey et al.28 C. albicans

C. tropicalis
E. floccosum. etc.

Romano Silvestri et al.29 C. albicans

R. Wyler et al.30 A. fumigatus

C. albicans
Penicillium sp.

International Journal of Pharmaceutical Sciences Review and Research

Available online at www.globalresearchonline.net 239
Int. J. Pharm. Sci. Rev. Res., 23(2), Nov – Dec 2013; nᵒ 41, 237-246 ISSN 0976 – 044X

K. Richardson et al. 31 C. albicans

Andreas Schaffne et al. 32 Ketoconazole Aspergillus fumigatus

A. flavus, A. niger
33
Garrett C Moraski E. coli
P. aeruginosa
S. aureus

R. J. Knox34 E. coli

Table 2: Imidazole as anticancer agent

Active against
Name of author Structure / Compound
specific celllines
B.K. Keppler et al. 35 Bis(imidazolium) (Imidazole)pentachlorouthenate P 388 Leukemia
36
Wen-Tai Li et al. P 388 leukemic cells

Balasubramanian NCI human cancer cell

Narasimhan et al.37

S. R. Ranganatha et al.38 Human leukemia cell

lines, K562 and CEM

Ippolito Antonini et al. 39 P 388 leukemia

Gyanendra Kumar Sharma DLA cells and EAC

40
et al. cells

International Journal of Pharmaceutical Sciences Review and Research

Available online at www.globalresearchonline.net 240
Int. J. Pharm. Sci. Rev. Res., 23(2), Nov – Dec 2013; nᵒ 41, 237-246 ISSN 0976 – 044X

Table 3: Imidazole as Analgesic & Anti-inflammatory agent

Name of author Structure

41
Tina M. Ross et al.

42
Paul E. Bender et al.

Joseph G. Lombardino
43
et al.

Luigi Almirante et al. 44

Emilio Toja et al. 45

Robert E. Boyd et al. 46

Carl R. Illig et al. 47

Robert E. Boyd et al.48

Andre J. Zaharenko et
al49

Table 4: Imidazole as Antiviral agent

Name of author Structure; Activity against virus
Bozenna Golankiewicz VIRUS: Influenza A virus, respiratory
et al. 50 syncytial virus.

Jerzy Boryski et al.51

VIRUS: DNA viruses including herpes simplex virus (HSV-1 , HSV-2) ,vaccinia
virus,varicella-zoster virus, cytomegalo virus.

International Journal of Pharmaceutical Sciences Review and Research

Available online at www.globalresearchonline.net 241
Int. J. Pharm. Sci. Rev. Res., 23(2), Nov – Dec 2013; nᵒ 41, 237-246 ISSN 0976 – 044X

Prem C. Srivastava et
52 VIRUS: Herpes virus, rhino virus,
al.
parainfluenza virus, vaccinia virus.

Rosario Alonso et al. 53 VIRUS: Herpes simplex virus type 1 (HSV-1) and
vesicular stomatitis virus.

Jerzy Boryski et al. 54

VIRUS: HSV-1 and HSV-2

Tun-Cheng Chien et al.55

VIRUS: Herpes simplex virus type-1(HSV-1),
human cytomegalovirus (HCMV).

Zhijian Zhu et al. 56

VIRUS:Human cytomegalovirus (HCMV)

Table 5: Imidazole as Anthelmintic Agent57-59 & Antitrichomonal Agent60

Name of author Structure

57
Richard J. Bochis et al.

58
R. D. Haugwitz et al.

59
Laird F. Miller et al.

60
K. Butler et al.

International Journal of Pharmaceutical Sciences Review and Research

Available online at www.globalresearchonline.net 242
Int. J. Pharm. Sci. Rev. Res., 23(2), Nov – Dec 2013; nᵒ 41, 237-246 ISSN 0976 – 044X

Table 6: Imidazole as Anticonvulsant Agent

Name of author Structure
61
Keith A. M. Walker et al.

Dante Nardi et al.62

63
David W. Robertson et al.

64
Rahul Mishra et al.

Table 7: Imidazole as Antiulcer Agent 65 & Agonists for Gastrointestinal Disorders 66

Name of author Structure

65
James J. Kaminski et al.

Henry J. Breslin et al.66

Table 8: Imidazole as Antiallergic Agent

Name of author Structure

67
Ian R. Ager et al.

CONCLUSION regioselective synthesis were well documented. On the

basis of the literature it was found that imidazole was
Imidazole is a five membered heterocyclic compound.
synthesized under solvent free condition with the help of
There were so many different conventional methods to
efficient and reusable catalyst & good yield was achieved
synthesize imidazole and its derivatives by researchers,
using ammonium acetate along with polyethylene glycol.
where dicarbonyl compound, ammonia & aldehyde were
Imidazole is a base in nature due to nitrogen atom. It
found to be good starting materials for the synthesis of
under goes electrophilic substitution but nucleophilic
imidazole; even microwave assisted synthesis,
substitution is rare one. From the extensive literature

International Journal of Pharmaceutical Sciences Review and Research

Available online at www.globalresearchonline.net 243
Int. J. Pharm. Sci. Rev. Res., 23(2), Nov – Dec 2013; nᵒ 41, 237-246 ISSN 0976 – 044X

survey it was found that it has antimicrobial, anticancer, 14. Bhatnagar A, Sharma PK, Kumar N, A Review on “Imidazoles”: Their
Chemistry and Pharmacological Potentials, International Journal of
analgesic , antiinflammatory, anticonvulsant, antiviral,
Pharm Tech Research, 3,1, 2011, 268-282.
anthelmintic, antiulcer, antiallergic activity etc. So from
the above discussion it can be concluded that imidazole is 15. http://en.wikipedia.org/wiki/Imidazole.
a therapeutically active versatile moiety, which had been 16. Amir M, Ahsan I, Akhter W, Khan SA, Ali I, Design and synthesis of
exploited in the past years for synthesizing various some azole derivatives containing 2,4,5-triphenyl imidazole moiety
as anti-inflammatory and antimicrobial agents, Indian Journal of
compounds having diverse pharmacological activities, and
Chemistry, 50B,2011,207-213.
still imidazole can be further utilized for the future
prospective against various diseases or disorders. 17. Dixon D, Shadomy S, Shadomy HJ, Espinel-Ingroff A, Kerkering TM,
Comparison of the in Vitro Antifungal Activities of Miconazole and
REFERENCES a New Imidazole, R41,400, The Journal of Infectious Diseases,
138,2,1978,245-248.
1. I.L. Finar, Organic Chemistry: Stereochemistry & the chemistry of
natural products, 5, 2, ELBS Longman Group Ltd., London, 2009, 18. Cosgrove RF, Beezer AE, Miles RJ, In vitro studies of amphotericin B
614-615. in combination with the imidazole antifungal compounds
clotrimazole and miconazole, The Journal of Infectious Diseases,
2. Ermolat’ev DS, Savaliya B, Shah A, Vander EE, One-pot microwave- 138,5,1978,681-685.
assisted protocol for the synthesis of substituted 2-amino-1H-
imidazoles, Mol Divers, 15,2011,491–496. 19. Wyler R, Murbach A, Möhl H, An Imidazole Derivative (Econazole)
as an Antifungal Agent in Cell Culture Systems, In Vitro, 15, 10,
3. Schmidt MA, DE Martin, Regioselective synthesis of 1,4- 1979, 745-750.
disubstituted imidazoles, Organic Biomolecular Chemistry,
10,2012,1079–1087. 20. Santo RD, Tafi A, Costi R, Botta M, Artico M, Corelli F, Forte M,
Caporuscio F, Angiolella L, Palamara AT, Antifungal agents. 11. N-
4. Rezaei Z, Khabnadideh S, Zomorodian K, Pakshir K, Kashi G, Substituted derivatives of 1-[(Aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-
Sanagoei N, Gholami S, Design, synthesis and antifungal activity of 1H-imidazole: synthesis, anti-Candida activity, and QSAR studies,
some new imidazole and triazole derivatives, Arch Pharm Chem Journal of Medicinal Chemistry, 48, 5,2005,140-153.
Life Sci, 344, 2011, 658–665.
21. Tafi A, Costi R, Botta M, Santo RD, Corelli F, Massa S, Ciacci A,
5. Chornous VA, Grozav AN, Bratenko MK, Vovk MV, Polyfunctional Manetti F, Artico M, Antifungal agents. 10. new derivatives of 1-
Imidazoles: ІV.Synthesis of 2-Aryl-4-chloro-1-methyl(aryl)-1H- [(Aryl)[4-aryl-1H-pyrrol-3-yl]methyl]-1H-imidazole, synthesis, anti-
imidazole-5-carbaldehydes, Russian Journal of Organic Chemistry, Candida activity, and quantitative structure-analysis relationship
47,10,2011,1527–1530. studies, Journal of Medicinal Chemistry, 45,2002,2720-2732.
6. Chornous VA, Grozav AN, Vovk MV, Polyfunctional Imidazoles: ІIІ. 22. Rossello A, Bertini S, Lapucci A, Macchia M, Martinelli A, Rapposelli
Synthesis of 1-Aryl-2,4-dihalo-1H-imidazole-5-carboxylic acids and S, Herreros E, Macchia B, Synthesis, antifungal activity, and
their derivatives, Russian Journal of Organic Chemistry, molecular modeling studies of new inverted oxime ethers of
4,8,2011,1194−1198. oxiconazole, Journal of Medicinal Chemistry, 45,2002, 4903-4912.
7. Das B, Sudhakar C, Srinivas Y, Efficient synthesis of 5-substituted 23. Walker KAM, Braemer AC, Hitt S, Jones RE, Matthews TR, 1- [ 4- (4-
2,3-diphenyl and 5-substituted 1-aryl-2,3-diphenyl imidazoles Chlorop heny1)-2- (2,6-dichlorop henylt hio) -n-butyl]- 1 H-
using polyethylene glycol, Synthetic Communications, 40, 2010, imidazole nitrate, a new potent antifungal agent, Journal of
2667–2675. Medicinal Chemistry, 21,8, 1978, 840-843.
8. Zhou CH , Gu XR, Xie RG, Cai MS, Convenient and Efficient 24. Tafi A, Anastassopoulou J, Theophanides T, Botta M, Corelli F,
Synthesis for a Series of Ether Bis-Imidazoles and Their Derivatives, Massa S, Artico M, Costi R, Santo RD, Ragno R, Molecular Modeling
Synthetic Communications, 29,7, 1999,1217-1222. of Azole Antifungal Agents Active against Candida albicans. 1. A
Comparative Molecular Field Analysis Study, Journal of Medicinal
9. Heravi MM, Zakeri M, Karimi N, Saeedi M, Oskooie HA, Hosieni NT,
Chemistry, 39,1996,1227-1235.
Acidic ionic liquid [(CH2)4SO3HMIM][HSO4]: a green media for the
simple and straightforward synthesis of 2,4,5-trisubstituted 25. Devadas B, Freeman SK, Zupec ME,Lu HF, Nagarajan SR, Kishore
imidazoles, Synthetic Communications, 40,2010,1998–2006. NS, Lodge JK, Kuneman DW, McWherter CA, Vinjamoori DV,
Getman DP, Gordon JI and Sikorski JA, Design and Synthesis of
10. Heravi MM, Zakeri M, Haghi H, MCM-41 mesoporous silica:
Novel Imidazole-Substituted Dipeptide Amides as Potent and
efficient and reusable catalyst for the synthesis of 2,4,5-
Selective Inhibitors of Candida albicans MyristoylCoA:Protein N-
trisubstituted imidazoles under solvent-free conditions, Synthesis
Myristoyltransferase and Identification of Related Tripeptide
and Reactivity in Inorganic, Metal-Organic, and Nano-Metal
Inhibitors with Mechanism-Based Antifungal Activity, Journal of
Chemistry, 41,2011,1310–1314.
Medicinal Chemistry, 40 , 1997, 2609-2625.
11. Bhosale SV, Kalyankar MB, Nalage SV, Bhosale DS, Pandhare SL,
26. Walker KAM, Hirschfeld DR, Marx M, Antimycotic Imidazoles. 2.
Kotbagi TV, Umbarkar SB,Dongare MK, One-pot synthesis of 2,4,5-
Synthesis and Antifungal Properties of Esters of 1-[2-
trisubstituted imidazoles using MoO3/SiO2, an efficient and
Hydroxy(mercapt0)-2-phenylethyl]-1 H-imidazoles, Journal of
recyclable catalyst, Synthetic Communications, 41, 2011, 762–769.
Medicinal Chemistry, 21,12,1978,1335-1338.
12. Shaabani A, Rahmati A, Aghaaliakbari B, Ghomi JS,
27. Heeres J, Backx LJJ, Mostmans JH, Cutsem JV, Antimycotic
1,1,3,3‐N,N,N′,N′‐Tetramethylguanidinium Trifluoroacetate Ionic
Imidazoles. Part 4. Synthesis and antifungal activity of
Liquid–Promoted Efficient One‐Pot Synthesis of Trisubstituted
ketoconazole, a new potent orally active broad-spectrum
Imidazoles, Synthetic Communications, 36,2006,65–70.
antifungal agent, Journal of Medicinal Chemistry, 22,8,1979,1003-
13. Mohammadizadeh MR, Hasaninejad A, Bahramzadeh M, 1005.
Trifluoroacetic acid as an efficient catalyst for one-pot, four-
28. Lovey RG, Elliott AJ, Kaminski JJ, Loebenberg D, Parmegiani RM,
component synthesis of 1,2,4,5-tetrasubstituted imidazoles under
Rane DF, Girijavallabhan VM, Pike RE, Guzik H, Antonacci B,
microwave-assisted, solvent-free conditions, Synthetic
Tomainet TY, Isobenzofurans as conformationally constrained
Communications, 39, 2009, 3232–3242.
miconazole analogues with improved antifungal potency, Journal
of Medicinal Chemistry, 35, 1992, 4221-4229.

International Journal of Pharmaceutical Sciences Review and Research

Available online at www.globalresearchonline.net 244
Int. J. Pharm. Sci. Rev. Res., 23(2), Nov – Dec 2013; nᵒ 41, 237-246 ISSN 0976 – 044X
29. Silvestri R, Artico M, Regina GL, Pasquali AD, Martino GD, D’Auria 45. Toja E, Selva D, Schiattit P, 3-Alkyl-2-aryl-3H-naphth[ 1,2-
FD, Nencioni L, Palamara AT,Imidazole Analogues of Fluoxetine, a d]imidazoles, a novel class of nonacidic antiinflammatory agents,
Novel Class of Anti-Candida Agents, Journal of Medicinal Journal of Medicinal Chemistry, 27,1984,610-616.
Chemistry, 47, 2004, 3924-3926.
46. Boyd RE, Rasmussen CR, Press JB, Raffa RB, Codd EE, Connelly CD,
30. Wyler R, Murbach A, Mohl H, An imidazoled erivative (econazole) Li QS, Martinez RP, Lewis MA, Almond HR, Reitz AB, α2
as an antifungal agent in cell culture systems, In Vitro, Adrenoceptor agonists as potential analgesic agents. 3.
15,10,1979,745-750. Imidazolylmethylthiophenes, Journal of Medicinal Chemistry, 44,
2001, 863-872.
31. Richardson K, Cooper K, Marriott MS, Tarbit MH, Troke PF, Whittle
PJ, Discovery of Fluconazole, a Novel Antifungal Agent, Reviews of 47. Illig CR, Manthey CL,Wall MJ, Meegalla SK, Chen J, Wilson KJ,
Infectious Diseases, 12, 3, 1990, S267-S271. Ballentine SK, DesJarlais RL, Schubert C, Crysler CS, Chen Y,Molloy
CJ, Chaikin MA, Donatelli RR, Yurkow E, Zhou Z,Player MR,
32. Schaffner A, Frick PG, The Effect of Ketoconazole on Amphotericin Tomczuk BE, Optimization of a potent class of arylamide colony-
B in a Model of Disseminated Aspergillosis, The Journal of stimulating factor-1 receptor inhibitors leading to anti-
Infectious Diseases, 151,5,1985,902-910. inflammatoryclinicalcandidate4-Cyano-N-[2-(1-cyclohexen-1-yl)-4-
33. Moraski GC, Thanassi JA, Podos SD, Pucci MJ, Miller MJ, One-step [1-[(dimethylamino)-acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-
syntheses of nitrofuranyl benzimidazoles that are active against carboxamide(JNJ-28312141), Journal of Medicinal Chemistry, 54,
multidrug-resistant bacteria,The Journal of Antibiotics, 64, 2011, 2011,7860−7883.
667–671. 48. Boyd RE, Press JB, Rasmussen CR, Raffa RB, Codd EE, Connelly CD,
34. Knox RJ, Knight RC, Edwards DI, Interaction of nitroimidazole drugs Bennett DJ, Kirifides AL, Gardocki JF, Reynolds B, Hortenstein JT,
with DNA in vitro structure-activity relationships, British Journal of Reitz AB, α2 Adrenoceptor agonists as potential analgesic agents.
Cancer, 44, 1981, 741-745. 1. (Imidazolylmethyl)oxazoles and –thiazoles, Journal of Medicinal
Chemistry, 42, 1999, 5064-5071.
35. Keppler BK, Wehe D, Endres H, Rupp W, Synthesis, antitumor
activity, and X-ray structure of Bis(imidazo1ium) (Imidazole) 49. Zaharenko AJ, Picolo G, Ferreira WA,Murakami T, Kazuma K,
pentachlororuthenate( III), (ImH)2 ( RuImCl5), Inorganic Chemistry, Hashimoto M, Cury Y, Freitas JC, Satake M, Konno K, Bunodosine
26,6, 1987, 844-846. 391: an analgesic acylamino acid from the venom of the sea
anemone bunodosoma cangicum, Journal of Natural Product, 74,
36. Li WT, Hwang DR, Song JS, Chen CP, Chen TW, Lin CH, Chuu JJ, Lien 2011, 378–382.
TW, Hsu TA, Huang CL, Tseng H, Lin CC, Lin HL, Chang CM, Chao
YS, Chen CT, Synthesis and biological evaluation of 2-amino-1- 50. Golankiewicz B, Januszczyk SP, Ikeda S, Balzarini J, Clercq ED,
thiazolyl imidazoles as orally active anticancer agents, Invest New Synthesis and antiviral activity of benzyl-substituted imidazo[1,5
Drugs, 30, 2012, 164–175. α]-1,3,5-triazine(5,8-Diaza-7,9-dideazapurine)derivatives, Journal
of Medicinal Chemistry, 38,1995,3558-3565.
37. Narasimhan B, Sharma D, Kumar P, Biological importance of
imidazole nucleus in the new millennium, Medicinal Chemistry 51. Boryski J, Golankiewicz B, Clercqt ED, Synthesis and antiviral
Research, 20, 2011, 1119–1140. activity of 3-substituted derivatives of 3,9-Dihydro-9-oxo-5H-
imidazo[1,2 -a ]purines, tricyclic analogues of acyclovir and
38. Ranganatha SR, Kavitha CV, Vinaya K,Prasanna DS, Chandrappa S, ganciclovir, Journal of Medicinal Chemistry, 34,1991,2380-2383.
Raghavan SC, Rangappa KS, Synthesis and Cytotoxic Evaluation of
Novel 2-(4-(2,2,2-Trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H- 52. Srivastava PC, Streeter DG, Matthews TR, Allen LB, Sidwell RW,
benzo[d]imidazole Derivatives, Archives of Pharmacal Research, Robins RK, Synthesis and antiviral and antimicrobial activity of
32, 10, 2009, 1335-1343. certain 1-β-D-Ribofuranosyl-4,5-Disubstituted imidazoles, Journal
of Medicinal Chemistry, 19,8, 1976, 1020-1026.
39. Antonini I, Claudi F, Cristalli G, Franchetti P, Grifantini M Martelli S,
Heterocyclic quinones with potential antitumor activity, synthesis 53. Alonso R, Andres JI, Garcia-Lopez MT, Heras FGD, Herranz R,
and antitumor activity of some benzimidazole-4,7-dione Alarcon B, Carrasco L, Synthesis and antiviral evaluation of
derivatives, Journal of Medicinal Chemistry, 31,1988,260-264. nucleosides of 5-Methylimidazole-4-carboxamide, Journal of
Medicinal Chemistry, 28,1985,834-838.
40. Sharma GK, Kumar S, Pathak D, Synthesis, antibacterial and
anticancer activities of some novel imidazoles, Der Pharmacia 54. Boryski J, Golankiewicz B, Clercq ED, Synthesis and antiviral activity
Lettre, 2, 2, 2010, 223-230. of novel N-Substituted derivatives of acyclovir, Journal of
Medicinal Chemistry, 31,1988,1351-1355.
41. Ross TM, Jetter MC, McDonnell ME, Boyd RE, Connelly CD,
Martinez RP, Lewis MA, Codd EE, Raffa RB, Reitz AB, α2 55. Chien TC, Saluja SS, Drach JC, Townsend LB, Synthesis and antiviral
Adrenoceptor agonists as potential analgesic agents. 2. discovery evaluation of polyhalogenated imidazole nucleosides: Dimensional
of 4-(4-Imidazo)-1,3-dimethyl-6,7-dihydrothianaphthene as a High- analogues of 2,5,6-Trichloro-1-(β-D-ribofuranosyl)benzimidazole,
Affinity Ligand for the α2D Adrenergic Receptor, Journal of Journal of Medicinal Chemistry,47,2004,5743-5752.
Medicinal Chemistry, 43, 2000, 1423-1426. 56. Zhu Z, Drach JC, Townsend LB, Synthesis of 2,6,7-Trichloro-1-(β-D-
42. Bender PE, Hill DT, Offen PH, Razgaitis K, Lavanchy P, Stringer OD, ribofuranosyl)naphtho[2,3-d] imidazole: A linear dimensional
Sutton BM, Griswold DE, DiMartino M, Walz DT, Lantos I, Laddo analogue of the antiviral agent TCRB, The Journal of Organic
CB, 5,6-Diaryl-2,3-dihydroimidazo[2,l –b] thiazoles: A New Class of Chemistry, 63,1998,977-983.
immunoregulatory antiinflammatory agents, Journal of Medicinal 57. Bochis RJ, Olen LE, Fisher MH, Reamer RA, Isomeric
Chemistry, 28, 1985, 1169-1177. phenylthioimidazo [1,2-a] pyridines as anthelmintics, Journal of
43. Lombardino JG, Wiseman EH, Preparation and antiinflammatory Medicinal Chemistry, 24,1981,1483-1487.
activity of some nonacidic trisubstituted imidazoles, Journal of 58. Haugwitz RD, Maurer BV, Jacobs GA, Narayanan VL, Antiparasitic
Medicinal Chemistry, 17, 1974, 1182-1188. agents. 3. Synthesis and anthelmintic activities of novel 2-P
44. Almirante L, Polo L, Mugnaini A, Provincialli E, Rugarli P, Biancotti yridinyl-5-isothiocyanatobenzimidazoles, Journal of Medicinal
A, Gamba A, Murmann W, Derivatives of imidazole. I. synthesis Chemistry, 22,9,1979,1113-1118.
and reactions of imidazo[l,2-a]pyridines with analgesic, 59. Miller LF, Bambury RE, 1H-Imidazo [1,2-a] imidazo1es, Journal of
antiinflammatory, antipyretic, and anticonvulsant activity, Journal Medicinal Chemistry, 15,4,1972,415-417.
of Medicinal Chemistry, 8,1965,305-312.

International Journal of Pharmaceutical Sciences Review and Research

Available online at www.globalresearchonline.net 245
Int. J. Pharm. Sci. Rev. Res., 23(2), Nov – Dec 2013; nᵒ 41, 237-246 ISSN 0976 – 044X
60. Butler K, Howes HL, Lynch JE, Pirie DK, Nitroimidazole derivatives. 65. Kaminski JJ, Perkins DG, Frantz JD, Solomon DM, Elliott AJ, Chiu
Relationship between structure and antitrichomonal activity, PJS, Long JF, Antiulcer agents. 3. structure- activity-toxicity
Journal of Medicinal Chemistry, 10, 1967,891-897. relationships of substituted imidazo[ 1,2 a] pyridines and a related
imidazo [1,2-a] pyrazine, Journal of Medicinal Chemistry,
61. Walker KAM,Wallach MB, Hirschfeld DR, 1-(Naphthylalky1)-1H - 30,1987,2047-2051.
imidazole derivatives, a new class of anticonvulsant agents, Journal
of Medicinal Chemistry,24, 1981,67-74. 66. Breslin HJ, Miskowski TA, Rafferty BM, Coutinho SV, Palmer
JM,Wallace NH, Schneider CR, Kimball ES, Zhang SP, Li J, Colburn
62. Nardi D, Tajana A, Leonardi A, Pennini R, Portioli F, Magistretti MJ, RW, Stone DJ, Martinez RP, He W, Rationale, design, and synthesis
Subissi A, Synthesis and anticonvulsant activity of N- of novel phenyl imidazoles as opioid receptor agonists for
(Benzoylalky1)imidazoles and N-(ω-Phenyl-ω- gastrointestinal disorders, Journal of Medicinal Chemistry,
hydroxyalky1)imidazoles, Journal of Medicinal Chemistry, 47,2004,5009-5020.
24,1981,721-731.
67. Ager IR, Barnes AC, Danswan GW, Hairsine PW, Kay DP, Kennewell
63. Robertson DW, Krushinski JH, Beedle EE, Leander JD,Wong DT, PD, Matharu SS, Miller P, Robson P, Rowlands DA, Tully WR,
Rathbun RC, Structure-activity relationships of (Arylalky1)imidazole Westwood R, Synthesis and oral antiallergic activity of carboxylic
anticonvulsants: Comparison of the (Fluorenylalky1)imidazoles acids derived from imidazo[2,l-c] [1,4]benzoxazines, imidazo[ 1,2-a
with nafimidone and denzimol, Journal of Medicinal Chemistry, ]quinolines, imidazo[ 1,2-a ]quinoxalines, imidazo[ 1,2-a
29,1986,1577-1586. ]quinoxalinones, pyrrolo[ 1,2-a ]quinoxalinones, pyrrolo[ 2,3-a
64. Mishra R, Ganguly S, Imidazole as an anti-epileptic: an overview, ]quinoxalinones, and imidazo[ 2,l-b ] benzothiazoles, Journal of
Medicinal Chemistry Research, 21, 12, 2012, 3929-3939. Medicinal Chemistry, 31,1988,1098-1115.

Source of Support: Nil, Conflict of Interest: None.

International Journal of Pharmaceutical Sciences Review and Research

Available online at www.globalresearchonline.net 246